Standard-dose osimertinib for refractory leptomeningeal metastases in T790M-positive EGFR -mutant non-small cell lung cancer

2018

Standard-dose osimertinib for refractory leptomeningeal metastases in T790M-positive EGFR -mutant non-small cell lung cancer

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

18

References

41

Citations